- Home
- NTRB vs BUJA Comparison
NTRB vs BUJA Comparison
Compare NTRB & BUJA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- BUJA
- Stock Information
- Founded
- NTRB 2016
- BUJA 2022
- Country
- NTRB United States
- BUJA Malaysia
- Employees
- NTRB N/A
- BUJA N/A
- Industry
- NTRB Industrial Specialties
- BUJA Blank Checks
- Sector
- NTRB Health Care
- BUJA Finance
- Exchange
- NTRB Nasdaq
- BUJA Nasdaq
- Market Cap
- NTRB 77.9M
- BUJA N/A
- IPO Year
- NTRB N/A
- BUJA 2023
- Fundamental
- Price
- NTRB $6.17
- BUJA $10.96
- Analyst Decision
- NTRB
- BUJA
- Analyst Count
- NTRB 0
- BUJA 0
- Target Price
- NTRB N/A
- BUJA N/A
- AVG Volume (30 Days)
- NTRB 28.2K
- BUJA 2.7K
- Earning Date
- NTRB 12-11-2024
- BUJA 01-01-0001
- Dividend Yield
- NTRB N/A
- BUJA N/A
- EPS Growth
- NTRB N/A
- BUJA N/A
- EPS
- NTRB N/A
- BUJA 0.29
- Revenue
- NTRB $1,803,816.00
- BUJA N/A
- Revenue This Year
- NTRB N/A
- BUJA N/A
- Revenue Next Year
- NTRB N/A
- BUJA N/A
- P/E Ratio
- NTRB N/A
- BUJA $37.13
- Revenue Growth
- NTRB N/A
- BUJA N/A
- 52 Week Low
- NTRB $1.93
- BUJA $10.30
- 52 Week High
- NTRB $9.60
- BUJA $12.18
- Technical
- Relative Strength Index (RSI)
- NTRB 50.57
- BUJA 67.66
- Support Level
- NTRB $5.24
- BUJA $10.85
- Resistance Level
- NTRB $6.40
- BUJA $10.85
- Average True Range (ATR)
- NTRB 0.71
- BUJA 0.00
- MACD
- NTRB -0.12
- BUJA -0.00
- Stochastic Oscillator
- NTRB 33.23
- BUJA 87.50
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About BUJA Bukit Jalil Global Acquisition 1 Ltd.
Bukit Jalil Global Acquisition 1 Ltd is a blank check company.